Esa Rintala
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing 9
- Urology top 2%
- Epidemiology top 5%
- Sepsis Diagnosis and Treatment 15
-
- Bladder and Urothelial Cancer Treatments 16
- Urinary and Genital Oncology Studies 7
-
- Streptococcal Infections and Treatments 8
- Neonatal and Maternal Infections 6
-
- Antimicrobial Resistance in Staphylococcus 5
-
- Hematological disorders and diagnostics 5
- Co-authors
- Timo J. NevalainenPirkko KotilainenOlli-Pekka SeppäläSverker HellstenRolf WahlqvistEinar HannisdalPer M. HellströmVesa Rasi
- Journals
- Intensive Care Medicine (3 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Journal of Internal Medicine (2 papers)
- Partner nations
- FinlandSwedenUnited States
In The Last Decade
Esa Rintala
61 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 120
- Critical Care and Intensive Care Medicine 183
- Clinical Biochemistry 211
- Urology 166
- Epidemiology 762
- Applied Microbiology and Biotechnology 38
Countries citing papers authored by Esa Rintala
This map shows the geographic impact of Esa Rintala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esa Rintala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esa Rintala more than expected).
Fields of papers citing papers by Esa Rintala
This network shows the impact of papers produced by Esa Rintala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esa Rintala. The network helps show where Esa Rintala may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Esa Rintala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 2 | |
| 4 | 2020 | 8 | |
| 5 | 2020 | 74 | |
| 6 | 2020 | 6 | |
| 7 | 2020 | 34 | |
| 8 | 2019 | 11 | |
| 9 | 2016 | 18 | |
| 10 | 2012 | 11 | |
| 11 | 2005 | 50 | |
| 12 | 2000 | 30 | |
| 13 | 2000 | 105 | |
| 14 | 1998 | 69 | |
| 15 | 1997 | 26 | |
| 16 | 1997 | 7 | |
| 17 | 1994 | 26 | |
| 18 | 1992 | 48 | |
| 19 | 1991 | 19 | |
| 20 | 1991 | 55 |
About Esa Rintala
Esa Rintala is a scholar working on Clinical Biochemistry, Critical Care and Intensive Care Medicine, Family Practice, Epidemiology and Molecular Medicine, having authored 66 papers that have together received 2.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (16 papers), Sepsis Diagnosis and Treatment (15 papers), Bacterial Identification and Susceptibility Testing (9 papers), Streptococcal Infections and Treatments (8 papers), Urinary and Genital Oncology Studies (7 papers), Neonatal and Maternal Infections (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Hematological disorders and diagnostics (5 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (183 citations), Clinical Biochemistry (211 citations), Urology (166 citations), Epidemiology (762 citations) and Applied Microbiology and Biotechnology (38 citations). Esa Rintala has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Timo J. Nevalainen, Pirkko Kotilainen, Olli-Pekka Seppälä, Sverker Hellsten, Rolf Wahlqvist, Einar Hannisdal, Per M. Hellström, Vesa Rasi, J Nikoskelainen and Raija Uusitalo‐Seppälä. Their work appears in journals such as Intensive Care Medicine, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Internal Medicine, Critical Care Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.